Template:EBM yellow
From Pubdrug
(List of links)
< Template:EBM yellowThe following pages link to here:
View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500).- User:W
- Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA) (inclusion)
- Carvedilol or Metoprolol European Trial (COMET) (inclusion)
- Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate (inclusion)
- Effect of risedronate on the risk of hip fracture in elderly women (HIP) (inclusion)
- Collaborative Atorvastatin Diabetes Study (CARDS)
- Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET)
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy (inclusion)
- Effect of Niacin on Lipid Levels and Glycemic Control in Patients With Diabetes: The ADMIT Study
- Renoprotective Effect of Irbesartan in Patients With Nephropathy due to Type 2 Diabetes (inclusion)
- Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM trial (inclusion)
- Template:EBM blue
- A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients with Type 2 Diabetes (inclusion)
- Cardiometabolic Risk in Impaired Fasting Glucose and Impaired Glucose Tolerance
